The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Thu., Mar. 28, 1:14 PM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #66. BioTelemetry, Inc. Cardiac Patient Services Business of Biomedical Systems, Corp.

Acquirer: BioTelemetry, Inc. (NASDAQ:BEAT)
Acquiree: Cardiac Patient Services Business of Biomedical Systems, Corp.
Details: BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced that it has entered into a definitive agreement to acquire the cardiac patient services business of Biomedical Systems, Corp. ("BMS") for aggregate consideration of $8.65 million at closing. Post integration, the acquisition is expected to generate $8.0 to $9.0 million in revenue and $2.5 to $3.0 million in EBITDA on an annualized basis. The transaction is expected to close in early April.

HeartBeam is a medical technology company primarily focusing on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. Co.'s initial focus is providing diagnostic data to help physicians with care management of patients with cardiovascular disease. Co. is developing its telehealth Product to address the field of remote patient monitoring. Co.'s telehealth Product is comprised of a credit card sized ECG machine and a cloud-based diagnostic software exert system. Co. is applying its platform technology to create a software tool for detecting heart attacks in the Emergency Room environment.

Open the BEAT Page at The Online Investor »

Company Name: 
Heartbeam Inc
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding BEAT: 
2
Total Market Value Held by ETFs: 
$1.26M
Total Market Capitalization: 
$57.00M
% of Market Cap. Held by ETFs: 
2.22%
 

Open the BEAT Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree BEAT Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (4.00 out of 4)
97th percentile
(ranked higher than approx. 97% of all stocks covered)

Analysts' Target Price:
BEAT Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 66 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.